Dermata Therapeutics DRMA Falls 4 as Stock Tests Key Support at 123 Asias Wealthy Families Fear Losing Fortune Yet Lack Succession Plans Survey Virtu Financial Q1 2026 Earnings Stellar EPS Beat Driven by Strong Market Making Performance US Strategic Petroleum Reserve Nears 40Year Low The Real Story Behind the Decline